Perilipin5 protects against non-alcoholic steatohepatitis by increasing 11-Dodecenoic acid and inhibiting the occurrence of ferroptosis

Xinming Xu; Jin Qiu; Xiaoya Li; Juntong Chen; Yue Li; Xinmei Huang; Shufei Zang; Xinran Ma; Jun Liu

doi:10.1186/s12986-023-00751-2

Perilipin5 protects against non-alcoholic steatohepatitis by increasing 11-Dodecenoic acid and inhibiting the occurrence of ferroptosis

Nutr Metab (Lond). 2023 Jun 22;20(1):29. doi: 10.1186/s12986-023-00751-2.

Authors

Xinming Xu^#¹, Jin Qiu^#², Xiaoya Li¹, Juntong Chen², Yue Li¹, Xinmei Huang¹, Shufei Zang³, Xinran Ma⁴, Jun Liu⁵

Affiliations

¹ Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, 200240, China.
² Shanghai Key Laboratory of Regulatory Biological, Institute of Biomedical Science, School of Life Science, East China Normal University, Shanghai, 200241, China.
³ Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, 200240, China. sophiazsf@fudan.edu.cn.
⁴ Shanghai Key Laboratory of Regulatory Biological, Institute of Biomedical Science, School of Life Science, East China Normal University, Shanghai, 200241, China. xrma@bio.ecnu.edu.cn.
⁵ Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, 200240, China. liu__jun@fudan.edu.cn.

^# Contributed equally.

Abstract

Background: Non-alcoholic steatohepatitis (NASH) is a major contributor to liver cirrhosis and hepatocellular carcinoma. There remains no effective pharmacological therapy. The hepatic lipid metabolism and fatty acid β-oxidation are regulated by Perilipin5 (Plin5). However, it is yet unknown how Plin5 affects NASH and the molecular process.

Methods: High-fat, high-cholesterol and high-fructose (HFHC) diets were used to mimic the progression of NASH in wild type (WT) mice and Plin5 knockout (Plin5 KO) mice. The degree of ferroptosis was measured by detecting the expression of key genes of ferroptosis and the level of lipid peroxide. The degree of NASH was judged by observing the morphology of the liver, detecting the expression of inflammation and fibrosis related genes of liver damage. Plin5 was overexpressed in the liver of mice by tail vein injection of adenovirus, and the process of NASH was simulated by methionine choline deficiency (MCD) diet. The occurrence of ferroptosis and NASH was detected by the same detection method. Targeted lipidomics sequencing was used to detect the difference in free fatty acid expression in the WT Plin5 KO group. Finally, it was verified in cell experiments to further study the effect of free fatty acids on ferroptosis of hepatocytes.

Results: In various NASH models, hepatic Plin5 was dramatically reduced. Plin5 knockout (KO) worsened NASH-associated characteristics in mice given a high-fat/high-cholesterol (HFHC) diet, such as lipid accumulation, inflammation and hepatic fibrosis. It has been shown that ferroptosis is involved in NASH progression. We revealed that Plin5 KO in mice aggravated the degree of ferroptosis in NASH models. Conversely, overexpression of Plin5 significantly alleviated ferroptosis and further ameliorated progression of MCD-induced NASH. Analysis of livers obtained from HFHC diet-fed mice by targeted lipidomics revealed that 11-Dodecenoic acid was significantly decreased in Plin5 KO mice. Addition of 11-Dodecenoia acid to Plin5 knockdown hepatocytes effectively prevented ferroptosis.

Conclusion: Our study demonstrates that Plin5 protects against NASH progression by increasing 11-Dodecenoic acid level and further inhibiting ferroptosis, suggesting that Plin5 has therapeutic potential as a target for the management of NASH.

Keywords: 11-Dodecenoic acid; Ferroptosis; NASH; Perilipin5; Steatosis.

Abstract

Grants and funding